Tetrahydrocarbazol-1-acetic acids: new class of thromboxane receptor antagonists.
Girard
Y
Y
Merck Frosst Canada Inc., Kirkland, Quebec.
Yoakim-Rancourt
C
C
Hamel
P
P
Gillard
J W
JW
Guindon
Y
Y
Letts
G
G
Evans
J
J
Léveillé
C
C
Ethier
D
D
Lord
A
A
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D002227:Carbazoles / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011982:Receptors, Prostaglandin / Q000378:metabolism; D017482:Receptors, Thromboxane; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013928:Thromboxane A2 / Q000378:metabolism
D000085:Acetates; D002227:Carbazoles; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; C061299:L 670596; D013928:Thromboxane A2